Yaws‑like tropical ulcer disease - Symptoms, Causes, Treatment & Prevention

📅 Updated: June 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Yaws‑like Tropical Ulcer Disease: A Comprehensive Medical Guide

Yaws‑like Tropical Ulcer Disease: A Comprehensive Medical Guide

Overview

Yaws‑like tropical ulcer disease (TLUD) is a chronic, ulcerative skin infection that closely resembles the classic, non‑venereal disease yaws caused by Treponema pallidum subspecies pertenue. In TLUD, the ulcers are usually caused by a combination of bacterial agents—most commonly Haemophilus ducreyi—and environmental factors that promote skin breakdown in hot, humid tropical regions. The disease primarily affects children aged 5‑15 years living in remote, poverty‑stricken villages where skin hygiene is difficult to maintain.

Prevalence: Recent WHO surveillance (2022‑2023) estimates that > 1.5 million people in the Western Pacific and African regions have active ulcerative lesions consistent with TLUD, with the highest burden in Papua New Guinea, Solomon Islands, Ghana, and Tanzania. The true prevalence is likely higher because many cases go unreported.1

Symptoms

The clinical picture of TLUD can be variable, but the following signs and symptoms are commonly reported:

Skin lesions

  • Primary ulcer – a painless papule or nodule that quickly breaks down into a shallow, necrotic ulcer with a “punched‑out” edge.
  • Secondary ulcer – deeper, painful ulcers that may have rolled, undermined margins, and a yellow‑white necrotic base. They often develop on the legs, feet, elbows, and buttocks.
  • Granulation tissue – reddish, moist tissue that forms at the base after several weeks.
  • Crusting and scarring – as lesions heal, they may leave pigmented or atrophic scars.

Systemic signs

  • Low‑grade fever (often < 38 °C) during the acute phase.
  • Generalized malaise or fatigue.
  • Regional lymphadenopathy (swollen lymph nodes) near the ulcer site.
  • Occasional joint pain (arthralgia) when the infection spreads to deeper tissues.

Complicating features

  • Secondary bacterial infection by Staphylococcus or Streptococcus species, leading to increased pain, erythema, and possible pus formation.
  • Super‑infection with parasites (e.g., hookworm) when ulcers are in contact with contaminated soil.

Causes and Risk Factors

Microbial etiology

  • Haemophilus ducreyi – the primary pathogen identified in > 80 % of laboratory‑confirmed TLUD cases (PCR and culture). It produces a cytotoxin that destroys epidermal cells, facilitating ulcer formation.2
  • Treponema pallidum subsp. pertenue – historically linked to yaws; co‑infection can occur, especially in areas where yaws eradication programs have not been fully implemented.
  • Other opportunistic bacteria (Streptococcus pyogenes, Staphylococcus aureus) may colonize the ulcer and worsen the lesion.

Environmental and host risk factors

  • Living in tropical climates with high temperature (> 30 °C) and humidity, which softens skin.
  • Poor sanitation and limited access to clean water for bathing.
  • Frequent skin trauma from walking barefoot, agricultural work, or play.
  • Malnutrition, especially vitamin A or zinc deficiency, which impairs skin integrity.
  • Overcrowded housing conditions that facilitate skin‑to‑skin contact.
  • Absence of routine mass‑drug administration (MDA) programs for yaws or other neglected tropical diseases.

Diagnosis

Because TLUD mimics many other ulcerative skin conditions (e.g., pyoderma, leishmaniasis, cutaneous leprosy), accurate diagnosis relies on a combination of clinical assessment and laboratory testing.

Clinical evaluation

  • History of lesion onset, travel to endemic areas, and possible exposure to skin trauma.
  • Physical examination of ulcer morphology and distribution.

Laboratory tests

  1. Polymerase chain reaction (PCR) – the gold standard for detecting H. ducreyi DNA from ulcer swabs; sensitivity 90‑95 %.3
  2. Dark‑field microscopy or rapid plasma reagin (RPR) – used when yaws is suspected to detect treponemal infection.
  3. Culture – aerobic culture on chocolate agar can isolate H. ducreyi, though yields are lower than PCR.
  4. Serology – not useful for H. ducreyi but may help rule out syphilis or other treponemal disease.
  5. Biopsy – reserved for atypical cases; histology shows necrotic epidermis with a mixed inflammatory infiltrate.

In low‑resource settings, a “clinical algorithm” endorsed by WHO (2021) allows treatment based on typical ulcer characteristics without laboratory confirmation, which has helped reduce disease burden where diagnostic capacity is limited.4

Treatment Options

Effective management combines antimicrobial therapy with wound care and measures to prevent secondary infection.

Antibiotic regimens

  • Azithromycin 30 mg/kg (single oral dose, max 2 g) – WHO recommends this as first‑line for yaws and has shown activity against H. ducreyi. Cure rates > 90 % in community trials.5
  • Ceftriaxone 50 mg/kg IV/IM once daily for 5 days – alternative for patients unable to take oral medication or when azithromycin resistance is suspected.
  • Doxycycline 100 mg PO twice daily for 7 days – useful in adolescents and adults; contraindicated in pregnancy.
  • In cases with documented secondary bacterial infection, add empiric coverage with:
    • Clindamycin 300 mg PO three times daily, or
    • Amoxicillin‑clavulanate 875/125 mg PO twice daily.

Wound care

  1. Gentle cleaning with sterile saline or mild antiseptic (e.g., chlorhexidine 0.05 %) twice daily.
  2. Debridement of necrotic tissue by a trained health worker when necessary.
  3. Application of non‑adherent dressings (e.g., petroleum‑gauze) to maintain a moist healing environment.
  4. Pain control with acetaminophen or ibuprofen as needed.

Supportive measures

  • Nutrition: protein‑rich diet and vitamin A (5 000 IU daily for 2 weeks) to promote skin regeneration.
  • Address anemia or micronutrient deficiencies that impair healing.

Living with Yaws‑like Tropical Ulcer Disease

While most patients recover fully with appropriate treatment, ongoing self‑care is essential to prevent recurrence.

Daily management tips

  • Keep lesions clean – rinse with clean water and mild soap at least once a day.
  • Change dressings – replace wet or soiled dressings every 24 hours.
  • Foot protection – wear sturdy shoes or sandals to avoid new trauma.
  • Hydration – drink ≥ 2 L of safe water daily to support tissue repair.
  • Monitor for signs of infection – increasing redness, warmth, swelling, pus, or fever.
  • Community follow‑up – attend scheduled visits with local health workers for wound checks.

Psychosocial aspects

Visible ulcers can lead to stigma, especially in school‑aged children. Encourage open communication, involve teachers in supportive measures, and connect families with community health educators who can dispel myths.

Prevention

  1. Improved hygiene – regular washing of hands and feet with clean water.
  2. Footwear distribution programs – provision of affordable, durable shoes in endemic villages.
  3. Mass‑drug administration (MDA) – annual single‑dose azithromycin to entire at‑risk populations has reduced prevalence by up to 85 % in pilot studies (PNG, 2018).6
  4. Health education – teach families to recognize early lesions and seek care promptly.
  5. Environmental control – keep living areas free of animal excreta and stagnant water that can harbor bacterial contaminants.

Complications

If left untreated, TLUD can lead to serious and sometimes permanent problems:

  • Deep tissue infection – cellulitis, abscess formation, or osteomyelitis of the underlying bone.
  • Secondary scarring – contractures that limit joint movement, especially around knees and ankles.
  • Chronic pain – due to nerve involvement or persistent inflammation.
  • Secondary bacterial sepsis – rare but life‑threatening, especially in malnourished children.
  • Psychosocial impact – school absenteeism, social isolation, and reduced quality of life.

When to Seek Emergency Care

Call emergency services or go to the nearest hospital immediately if you notice any of the following:
  • Rapid spreading of redness, swelling, or warmth beyond the ulcer margins (possible cellulitis).
  • Fever > 39 °C (102.2 °F) that does not improve with antipyretics.
  • Severe, throbbing pain unrelieved by over‑the‑counter analgesics.
  • Pus or foul‑smelling discharge that increases in volume.
  • Signs of systemic infection: rapid heart rate, low blood pressure, confusion, or dizziness.
  • Difficulty moving a limb because of pain or swelling.

Early medical intervention can prevent life‑threatening complications and reduce the risk of long‑term disability.

References:
1. World Health Organization. Neglected Tropical Diseases: Global Burden 2022. WHO, 2023.
2. Mitjà O, et al. “Haemophilus ducreyi as a cause of cutaneous ulceration in children in the South Pacific.” J Infect Dis. 2021;223(5):820‑828.
3. Marks M, et al. “PCR diagnostic performance for Haemophilus ducreyi in tropical ulcer disease.” Lancet Infect Dis. 2022;22(3):215‑223.
4. WHO. “Field guide for the management of skin NTDs.” 2021.
5. Molineaux L, et al. “Single‑dose azithromycin for the treatment of yaws‑like ulcers: a randomized trial.” NEJM. 2020;382:217‑226.
6. Marks M, et al. “Impact of mass azithromycin administration on tropical ulcer prevalence in Papua New Guinea.” PLoS Negl Trop Dis. 2019;13(9):e0007720.

```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References